No recent analyst price targets found for BID.
Latest News for BID
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern
Tribeca Strategic Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Share Rights, Commencing on July 20, 2026
New York, NY, July 17, 2026 (GLOBE NEWSWIRE) -- Tribeca Strategic Acquisition Corp. (the “Company”) announced today that, commencing July 20, 2026, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BID.
U.S. House Trading
No House trades found for BID.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.